Norachem is a start-up that specialises in the use of generative design to create small molecule drugs. While computational approaches have become widespread in drug discovery in the last few years, most of the approaches have proved inadequate to solve the complex problem of creating molecules that satisfy multiple, often conflicting design goals. Generative design combines deep learning, artificial intelligence, graph theory, computational geometry, and genetic programming to search a near-infinite chemical space and produce molecular structures with optimal values for multiple objectives. The result is the production of better drug molecules faster. For more information, please contact amit at norachem dot io.
| Website | https://norachem.io/ |
| Employees | 2 (0 on RocketReach) |
| Founded | 2020 |
| Industry | Pharmaceutical Manufacturing |
| Keywords | Generative Design, Small Molecule Drugs, Drug Discovery, Computational Drug Design, Drug Development, In Silico Drug Design, Pharmaceutical Research, Molecular Modeling, Medicinal Chemistry, Ai Drug Discovery, Machine Learning Drug Discovery, Lead Optimization, Structure-Based Drug Design, Virtual Screening, Cheminformatics, Drug Design Software, Molecular Dynamics, Quantum Chemistry, Bioinformatics |
| Competitors | SABIC, BASF, Dow, LANXESS, Evonik, COVESTRO ELASTOMERS SAS, Mitsubishi Chemical Holdings America, Solvay, Huntsman Corporation, Arkema +40 more (view full list) |
Looking for a particular Norachem employee's phone or email?
Norachem is based in New York, New York.